PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $431,245 | +102.1% | 25,854 | +178.7% | 0.02% | +77.8% |
| Q1 2023 | $213,394 | +28.8% | 9,278 | -38.9% | 0.01% | -10.0% |
| Q4 2022 | $165,701 | +84.1% | 15,188 | +33.4% | 0.01% | +233.3% |
| Q2 2022 | $90,000 | -93.3% | 11,383 | -79.9% | 0.00% | -94.3% |
| Q1 2022 | $1,344,000 | +537.0% | 56,763 | +1105.2% | 0.05% | +278.6% |
| Q2 2021 | $211,000 | -19.8% | 4,710 | -63.9% | 0.01% | +27.3% |
| Q4 2020 | $263,000 | – | 13,030 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |